NeoGenomics is an industry-leading cancer reference laboratory serving oncologists, pathologists, academia, and drug development projects. Comprehensive diagnostic, prognostic, and predictive testing is available with >600 tests available in-house. Highlights include extensive molecular profiling in myeloid disorders and leukemias, a suite of cfDNA/RNA assays for biopsy-free evaluation of hematologic cancers, and >20 HemeFISH™ panels. Collaborations are welcome.